The latest for Multiple Myeloma

Prof Paul Richardson - Dana Farber Institute, Boston, USA
The latest for Multiple Myeloma ( Prof Paul Richardson - Dana Farber Institute, Boston, USA )
19 Dec 2011

Myelodysplastic syndrome drug development and combination therapy

Prof Valeria Santini – University of Florence, Italy
Myelodysplastic syndrome drug development and combination therapy ( Prof Valeria Santini – University of Florence, Italy )
19 Dec 2011

Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765

Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA
Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765  ( Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA )
19 Dec 2011

Update and new perspectives in the management of MDS

Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA
Update and new perspectives in the management of MDS ( Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA )
19 Dec 2011

New data on aggressive B cell lymphoma

Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA
New data on aggressive B cell lymphoma ( Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA )
19 Dec 2011

Update on the phase III VISTA trial

Dr Jesus San Miguel – University Hospital of Salamanca, Spain
Update on the phase III VISTA trial ( Dr Jesus San Miguel – University Hospital of Salamanca, Spain )
19 Dec 2011

Update on the development of proteasome inhibitors

Dr Philip McCarthy – Roswell Park Cancer Institute, USA
Update on the development of proteasome inhibitors ( Dr Philip McCarthy – Roswell Park Cancer Institute, USA )
19 Dec 2011

Romidepsin treatment in peripheral T cell lymphoma and subsets

Dr Francine Foss – Yale School of Medicine, Connecticut, USA
Romidepsin treatment in peripheral T cell lymphoma and subsets  ( Dr Francine Foss – Yale School of Medicine, Connecticut, USA )
19 Dec 2011

Optimal treatment schedule for pomalidomide in multiple myeloma

Prof Gareth Morgan, Royal Marsden Hospital, London, UK and Dr Xavier Leleu, Hôpital Huriez, CHRU Lille, France
Optimal treatment schedule for pomalidomide in multiple myeloma ( Prof Gareth Morgan, Royal Marsden Hospital, London, UK and Dr Xavier Leleu, Hôpital Huriez, CHRU Lille, France )
19 Dec 2011

Indolent non-Hodgkin’s Lymphoma in 2011: A game changing year

Dr Mathias Rummel - University Hospital, Giessen, Germany, Prof John Gribben – Barts and The London Trust Cancer Centre, UK and Prof Gilles Salles - Universite Claude Bernard Lyon, France
Indolent non-Hodgkin’s Lymphoma in 2011: A game changing year ( Dr Mathias Rummel - University Hospital, Giessen, Germany, Prof John Gribben – Barts and The London Trust Cancer Centre, UK and Prof Gilles Salles - Universite Claude Bernard Lyon, France  )
16 Dec 2011

The changing landscape for NHL treatment

Prof Bertrand Coiffier - Hospices Civils de Lyon, France
The changing landscape for NHL treatment ( Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
16 Dec 2011

Anaemia management update: blood transfusion and ESA use in oncology

Prof Matti Aapro, Prof Valeria Santini, Dr Joachim Fandrey, Dr Richard Delarue and Prof Donat Spahn
Anaemia management update: blood transfusion and ESA use in oncology ( Prof Matti Aapro, Prof Valeria Santini, Dr Joachim Fandrey, Dr Richard Delarue and Prof Donat Spahn  )
15 Dec 2011